As detailed below, this Bristol-Myers position achieved a return-on-investment result of +1.6% absolute return in 41 days (equivalent to a +14.6% annualized return-on-investment).
1. Bristol-Myers Squibb Co. -- BMY Covered Calls Position Closed
The buy/write transaction was:
03/15/2019 Bought 1,000 Bristol-Myers shares @ $49.08
03/15/2019 Sold 10 BMY 4/18/2019 $46.00 Call options @ $3.85
Note: the Open Interest in these Call options was 1,450 contracts (sufficiently liquid for a tight bid/ask price spread) and the Implied Volatility was 36.4 when this transaction was executed.
04/04/2019 Quarterly ex-dividend of $410.00 = $.41 per share x 1,000 shares
04/18/2019 10 BMY 4/18/2019 $46.00 Call options expired
Note: the price of BMY was $45.52 at options expiration.
04/25/2019 Sold 1,000 BMY shares at $45.565 per share
The overall performance result (including commissions) for this Bristol-Myers Covered Calls position are as follows:
Covered Calls Cost Basis: $45,241.65
= ($49.08 - $3.85) * 1,000 shares + $11.65 commissions
Net Profit Components:
(a) Options Income: +$3,850.00
= ($3.85*1,000 shares)
(b) Dividend Income: +$410.00
= ($.41 dividend per share x 1,000 shares)
(c) Capital Appreciation (1,000 BMY share sold at $45.565 per share): -$3,519.95
+($45.565 - $49.08)*1,000 shares - $4.95 commissions
+($45.565 - $49.08)*1,000 shares - $4.95 commissions
= (+$3,850.00 options income +$410.00 dividend income -$3,519.95 capital appreciation)
Absolute Return: +1.6%
Absolute Return: +1.6%
= +$740.05/$45,241.65
Annualized Return (If BMY stock assigned at $46.00 at Apr 18, 2018 expiration): +14.6%
= (+$740.05/$45,241.65)*(365/41 days)